NKTR
Nektar Therapeutics (NKTR) Investor Questions
Review Nektar Therapeutics (NKTR) faq with company data, supporting context and links to related investor research.
Research record updated: . Individual measures may refer to different reporting periods.
- Company
- Nektar Therapeutics
- Sector
- Healthcare
- Industry
- Biotechnology
- Overall BTI score
- 44
- Annual revenue
- $55.23M
- Annual net income
- $-164.08M
- Annual free cash flow
- $-208.68M
Nektar Therapeutics (NKTR) Investor Questions research
Nektar Therapeutics trades under the ticker NKTR. The company is classified in the Healthcare sector and the Biotechnology industry.
Investors commonly review NKTR through its earnings trend, revenue, free cash flow, balance sheet, valuation and historical risk. Use the financial statements to check whether reported profit is supported by cash generation.